Model
Edge
4D Molecular Therapeutics
0001833453
Filing Type
4
Filing Date
6/17/2026
Updated
6/18/26, 3:39 PM
Copy Ref
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership